Investor
Eir Ventures
- Biotech
- Location:
- Stockholm, Sweden
Description
Eir Ventures, the Eir Ventures Partners AB, invests in Nordic life‑science startups, guiding translational teams through preclinical, clinical, and commercialization stages, and supports patients, clinicians, and researchers by advancing therapies for metabolic, neurodegenerative, and rare diseases.
Eir Ventures is located in the Stockholm ecosystem.
Related
4BIO Capital4BIO Capital invests in and supports early-stage companies developing advanced therapies, including cell and gene therapy, RNA-based…
AescapAescap builds and manages liquid life-sciences investment funds that concentrate in biotech companies applying AI to accelerate research…
Aldea VenturesAldea Ventures invests as a venture capital firm in computing, biology, and physical systems across Europe and the United States, using…
ALSA VenturesALSA Ventures invests in biotechnology companies developing novel therapeutics and modalities for a variety of disease areas, working with…
Axcend HealthAxcend Health develops and invests in early-stage biotechnology, digital health, and medical diagnostic or device companies, providing…
BeAble CapitalBeAble Capital invests in science-based technologies through science equity, leading rounds for Captoplastic’s microplastics removal…
Bionova CapitalBionova Capital manages its current portfolio of healthcare and life science startup investments after ending new deal activity, with…
Bioqube VenturesBioqube Ventures invests in and builds biotech companies that develop first- or best-in-class therapeutics for major unmet medical needs,…
Blue HorizonBlue Horizon invests across the sustainable food system to back technology and science entrepreneurs, providing lifecycle capital and…